Table 2.
IBD group (n=75) | CD group (n=44) | UC group (n=31) | healthy controls (n=20) | |
---|---|---|---|---|
Adiponectin (μg/ml) | 10.6 (8.2–13.3)* | 11.1 (8.5–13.3)* | 10.0 (7.8–13.3)* | 12.8 (11.0–14.1) |
Resistin (ng/ml) | 6.3 (4.8–8.5)** | 6.3 (5.1–8.4)* | 6.1 (4.8–8.9)* | 4.3 (3.0–5.7) |
WISP-1 (pg/ml) | 1296 (146–4286)** | 2917 (740–5198)**# | 373 (49–3004) | 311 (38–1905) |
RBP-4 (μg/ml) | 37.0 (27.0–48.4) | 37.6 (27.2–44.2) | 35.2 (26.4–52.4) | 42.9 (32.5–52.9) |
IBD = inflammatory bowel disease; CD = Crohn’s disease; UC = ulcerative colitis; WISP-1 = Wnt1-inducible signaling pathway protein-1; RBP-4 = retinol-binding protein-4. Values are expressed as median and interquartile range (25–75 percentile). Significant differences of patients group versus controls:
p<0.05,
p<0.01,
p<0.001; or CD versus UC groups:
p<0.05 according to Mann-Whitney U test.